|
|
|
Insider
Information: |
Burgstahler David F |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
127,648 |
|
Indirect Shares
|
32,047,702 |
|
|
Direct
Value |
$3,060,487 |
|
|
Indirect Value
|
$27,536,589 |
|
|
Total
Shares |
32,175,350 |
|
|
Total
Value |
$30,597,075 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
0
|
Stock
price went up :
|
8
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
8.0
|
0.0
|
Percentage
Gain/Loss : |
123.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Warner Chilcott Ltd |
WCRX |
Director |
2008-03-07 |
20,000 |
2007-03-12 |
0 |
Premium* |
|
Angiodynamics Inc |
ANGO |
Director, 10% Owner |
2017-04-12 |
23,988 |
2017-04-12 |
381,406 |
Premium* |
|
Syneos Health Inc |
SYNH |
Director, 10% Owner |
2017-05-23 |
38,758 |
2017-05-23 |
3,648 |
Premium* |
|
Lantheus Holdings, Inc. |
LNTH |
Director |
2017-09-07 |
13,248 |
2017-09-07 |
39,831 |
Premium* |
|
Wideopenwest, Inc. |
WOW |
Director |
2018-01-10 |
31,654 |
2018-01-10 |
3,733 |
Premium* |
|
Organogenesis Holdings Inc |
ORGO |
|
2019-08-19 |
0 |
2021-05-14 |
7,888,220 |
Premium* |
|
Osmotica Pharmaceuticals Plc |
OSMT |
Director, 10% Owner |
2020-11-20 |
0 |
2023-01-27 |
23,730,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ORGO |
Organogenesis Holdings In... |
|
|
2020-03-12 |
4 |
B |
$3.62 |
$1,281,541 |
I/I |
332,349 |
25,307,514 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2020-03-16 |
4 |
B |
$3.98 |
$298,133 |
I/I |
75,000 |
25,517,514 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2020-03-13 |
4 |
B |
$4.31 |
$581,283 |
I/I |
135,000 |
25,442,514 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2020-11-18 |
4 |
B |
$4.68 |
$212,519 |
I/I |
45,378 |
29,885,549 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-03 |
4 |
B |
$4.75 |
$949,760 |
I/I |
200,000 |
17,199,665 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-05 |
4 |
B |
$4.89 |
$868,571 |
I/I |
177,600 |
17,577,265 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-04 |
4 |
B |
$4.90 |
$979,220 |
I/I |
200,000 |
17,399,665 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2020-11-19 |
4 |
B |
$4.97 |
$179,613 |
I/I |
36,127 |
29,921,676 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2020-11-20 |
4 |
B |
$4.99 |
$13,671 |
I/I |
2,739 |
29,924,415 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2020-11-24 |
4 |
B |
$5.00 |
$500 |
I/I |
100 |
29,924,515 |
0.01 |
% |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-09 |
4 |
B |
$5.12 |
$128,023 |
I/I |
25,000 |
18,102,265 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-06 |
4 |
B |
$5.18 |
$2,592,300 |
I/I |
500,000 |
18,077,265 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-10 |
4 |
B |
$5.18 |
$62,207 |
I/I |
12,000 |
18,114,265 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-11 |
4 |
B |
$5.75 |
$2,570,429 |
I/I |
447,000 |
18,561,265 |
0.01 |
- |
|
ORGO |
Organogenesis Holdings In... |
|
|
2019-09-12 |
4 |
B |
$6.25 |
$2,585,344 |
I/I |
413,900 |
18,975,165 |
0.01 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2016-11-21 |
4 |
S |
$9.00 |
$22,500,000 |
I/I |
(2,500,000) |
4,282,208 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-03-17 |
4 |
S |
$12.20 |
$36,600,000 |
I/I |
(3,000,000) |
3,442,208 |
0 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-05-09 |
4 |
S |
$13.40 |
$40,200,000 |
I/I |
(3,000,000) |
2,602,208 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
Director |
|
2016-08-05 |
4 |
S |
$14.62 |
$32,895,000 |
I/I |
(2,250,000) |
1,555,407 |
0 |
- |
|
WCRX |
Warner Chilcott Ltd |
Director |
|
2007-03-12 |
4 |
B |
$14.77 |
$147,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
LNTH |
Lantheus Holdings, Inc. |
Director |
|
2017-06-20 |
4 |
S |
$14.87 |
$44,610,000 |
I/I |
(3,000,000) |
1,762,208 |
0 |
- |
|
WCRX |
Warner Chilcott Ltd |
Director |
|
2008-03-07 |
4 |
B |
$15.65 |
$156,500 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
ANGO |
Angiodynamics Inc |
Director |
|
2016-11-18 |
4 |
S |
$15.68 |
$32,791,490 |
I/I |
(2,091,294) |
1,014,058 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
Director |
|
2016-11-18 |
4 |
D |
$15.68 |
$6,408,510 |
I/I |
(408,706) |
765,590 |
0 |
- |
|
ANGO |
Angiodynamics Inc |
Director |
|
2017-04-12 |
4 |
S |
$16.00 |
$37,600,000 |
I/I |
(2,350,000) |
381,406 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|